FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2129651625> ?p ?o ?g. }

• W2129651625 endingPage "1537" @default.
• W2129651625 startingPage "1532" @default.
• W2129651625 abstract "Patients with peripheral artery disease are at risk for critical limb ischemia and amputation. Accumulation of advanced glycation end products is increased and predictive for coronary and cerebrovascular events in several high cardiovascular risk groups. We hypothesized that accumulation of tissue advanced glycation end products, measured by skin autofluorescence (SAF), predicts amputation in patients with peripheral artery disease.Between October 2007 and June 2008, 252 patients with peripheral artery disease were included at the outpatient clinic. During a 5-year follow-up, 22 (9%) had an amputation because of critical limb ischemia. Competing risks regression analysis showed a subproportional hazard ratio of 3.05 (95% confidence interval [CI], 1.87-4.96); P<0.0001 for amputation per unit incease of SAF. After correction for diabetes mellitus and Fontaine stage, subproportional hazard ratio was 2.72 (95% CI, 1.38-5.39); P=0.004. In patients with Fontaine stage I and II only (n=215), SAF was the only predictor for amputation, subproportional hazard ratio 4.05 (95% CI, 2.09-7.83); P<0.0001. Fontaine stage multiplied by SAF resulted in a significant increase of the area under the curve for prediction of amputation when compared with Fontaine stage only: area under the curve increased from 0.74 (95% CI, 0.63-0.86) to 0.83 (95% CI, 0.74-0.92); P=0.003.Skin autofluorescence, as a measure of tissue advanced glycation end products deposition, predicts amputation in patients with peripheral artery disease during a 5-year follow-up, independent from the presence of diabetes mellitus and Fontaine stage. Even at lower Fontaine stage (I or II), SAF is a strong predictor of amputation. The multiplication of Fontaine stage by SAF results in a good prediction model of amputation." @default.
• W2129651625 created "2016-06-24" @default.
• W2129651625 creator A5013553232 @default.
• W2129651625 creator A5020305451 @default.
• W2129651625 creator A5061526582 @default.
• W2129651625 creator A5079661110 @default.
• W2129651625 creator A5081586369 @default.
• W2129651625 creator A5090172206 @default.
• W2129651625 date "2015-06-01" @default.
• W2129651625 modified "2023-10-06" @default.
• W2129651625 title "Skin Autofluorescence as a Measure of Advanced Glycation End Products Deposition Predicts 5-Year Amputation in Patients With Peripheral Artery Disease" @default.
• W2129651625 cites W1995903733 @default.
• W2129651625 cites W1997448590 @default.
• W2129651625 cites W2017189076 @default.
• W2129651625 cites W2031589276 @default.
• W2129651625 cites W2045506953 @default.
• W2129651625 cites W2068900191 @default.
• W2129651625 cites W2093941616 @default.
• W2129651625 cites W2101547977 @default.
• W2129651625 cites W2108762011 @default.
• W2129651625 cites W2111037557 @default.
• W2129651625 cites W2114419186 @default.
• W2129651625 cites W2120832973 @default.
• W2129651625 cites W2122567972 @default.
• W2129651625 cites W2132176130 @default.
• W2129651625 cites W2146181546 @default.
• W2129651625 cites W2148854235 @default.
• W2129651625 cites W2163425767 @default.
• W2129651625 cites W2887712073 @default.
• W2129651625 doi "https://doi.org/10.1161/atvbaha.115.305407" @default.
• W2129651625 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25882066" @default.
• W2129651625 hasPublicationYear "2015" @default.
• W2129651625 type Work @default.
• W2129651625 sameAs 2129651625 @default.
• W2129651625 citedByCount "24" @default.
• W2129651625 countsByYear W21296516252016 @default.
• W2129651625 countsByYear W21296516252017 @default.
• W2129651625 countsByYear W21296516252018 @default.
• W2129651625 countsByYear W21296516252019 @default.
• W2129651625 countsByYear W21296516252020 @default.
• W2129651625 countsByYear W21296516252021 @default.
• W2129651625 countsByYear W21296516252022 @default.
• W2129651625 countsByYear W21296516252023 @default.
• W2129651625 crossrefType "journal-article" @default.
• W2129651625 hasAuthorship W2129651625A5013553232 @default.
• W2129651625 hasAuthorship W2129651625A5020305451 @default.
• W2129651625 hasAuthorship W2129651625A5061526582 @default.
• W2129651625 hasAuthorship W2129651625A5079661110 @default.
• W2129651625 hasAuthorship W2129651625A5081586369 @default.
• W2129651625 hasAuthorship W2129651625A5090172206 @default.
• W2129651625 hasBestOaLocation W21296516251 @default.
• W2129651625 hasConcept C126322002 @default.
• W2129651625 hasConcept C134018914 @default.
• W2129651625 hasConcept C141071460 @default.
• W2129651625 hasConcept C147990577 @default.
• W2129651625 hasConcept C164705383 @default.
• W2129651625 hasConcept C207103383 @default.
• W2129651625 hasConcept C2776204877 @default.
• W2129651625 hasConcept C2777466421 @default.
• W2129651625 hasConcept C2778213512 @default.
• W2129651625 hasConcept C2781099653 @default.
• W2129651625 hasConcept C3018348675 @default.
• W2129651625 hasConcept C44249647 @default.
• W2129651625 hasConcept C46762472 @default.
• W2129651625 hasConcept C50382708 @default.
• W2129651625 hasConcept C541997718 @default.
• W2129651625 hasConcept C555293320 @default.
• W2129651625 hasConcept C71924100 @default.
• W2129651625 hasConcept C76318530 @default.
• W2129651625 hasConceptScore W2129651625C126322002 @default.
• W2129651625 hasConceptScore W2129651625C134018914 @default.
• W2129651625 hasConceptScore W2129651625C141071460 @default.
• W2129651625 hasConceptScore W2129651625C147990577 @default.
• W2129651625 hasConceptScore W2129651625C164705383 @default.
• W2129651625 hasConceptScore W2129651625C207103383 @default.
• W2129651625 hasConceptScore W2129651625C2776204877 @default.
• W2129651625 hasConceptScore W2129651625C2777466421 @default.
• W2129651625 hasConceptScore W2129651625C2778213512 @default.
• W2129651625 hasConceptScore W2129651625C2781099653 @default.
• W2129651625 hasConceptScore W2129651625C3018348675 @default.
• W2129651625 hasConceptScore W2129651625C44249647 @default.
• W2129651625 hasConceptScore W2129651625C46762472 @default.
• W2129651625 hasConceptScore W2129651625C50382708 @default.
• W2129651625 hasConceptScore W2129651625C541997718 @default.
• W2129651625 hasConceptScore W2129651625C555293320 @default.
• W2129651625 hasConceptScore W2129651625C71924100 @default.
• W2129651625 hasConceptScore W2129651625C76318530 @default.
• W2129651625 hasIssue "6" @default.
• W2129651625 hasLocation W21296516251 @default.
• W2129651625 hasLocation W21296516252 @default.
• W2129651625 hasOpenAccess W2129651625 @default.
• W2129651625 hasPrimaryLocation W21296516251 @default.
• W2129651625 hasRelatedWork W2126853518 @default.
• W2129651625 hasRelatedWork W2133235702 @default.
• W2129651625 hasRelatedWork W2188075744 @default.
• W2129651625 hasRelatedWork W2394861634 @default.
• W2129651625 hasRelatedWork W2395747709 @default.
• W2129651625 hasRelatedWork W2406397024 @default.

• next